These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 29683068)

  • 1. CD44 overexpression related to lymph node metastasis and poor prognosis of pancreatic cancer.
    Liu Y; Wu T; Lu D; Zhen J; Zhang L
    Int J Biol Markers; 2018 Aug; 33(3):308-313. PubMed ID: 29683068
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD24 Overexpression Related to Lymph Node Invasion and Poor Prognosis of Colorectal Cancer.
    Wang JL; Guo CR; Su WY; Chen YX; Xu J; Fang JY
    Clin Lab; 2018 Apr; 64(4):497-505. PubMed ID: 29739071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of CD44 in pancreatic cancer and its significance.
    Li XP; Zhang XW; Zheng LZ; Guo WJ
    Int J Clin Exp Pathol; 2015; 8(6):6724-31. PubMed ID: 26261555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinicopathological and prognostic value of CD24 expression in breast cancer: a meta-analysis.
    Liu G; Liu GX; Fang Y; Cao ZY; Du HH; Fu J; Qian K
    Int J Biol Markers; 2017 May; 32(2):e182-e189. PubMed ID: 28315505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Expression of stem cell markers CD44 and Lgr5 in colorectal cancer and its relationship with lymph node and liver metastasis].
    Wang XF; Zhang XL; Xu LP; Shi GG; Zheng HY; Sun BC
    Zhonghua Yi Xue Za Zhi; 2018 Sep; 98(36):2899-2904. PubMed ID: 30293346
    [No Abstract]   [Full Text] [Related]  

  • 6. Prognostic value of CD44 variant exon 6 expression in non-small cell lung cancer: a meta-analysis.
    Zhao S; He JL; Qiu ZX; Chen NY; Luo Z; Chen BJ; Li WM
    Asian Pac J Cancer Prev; 2014; 15(16):6761-6. PubMed ID: 25169522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD44v/CD44s expression patterns are associated with the survival of pancreatic carcinoma patients.
    Li Z; Chen K; Jiang P; Zhang X; Li X; Li Z
    Diagn Pathol; 2014 Apr; 9():79. PubMed ID: 24708709
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinicopathological and prognostic significance of cancer stem cell markers CD44 and CD133 in patients with gastric cancer: A comprehensive meta-analysis with 4729 patients involved.
    Lu L; Wu M; Sun L; Li W; Fu W; Zhang X; Liu T
    Medicine (Baltimore); 2016 Oct; 95(42):e5163. PubMed ID: 27759647
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD44 expression is predictive of poor prognosis in pharyngolaryngeal cancer: systematic review and meta-analysis.
    Chai L; Liu H; Zhang Z; Wang F; Wang Q; Zhou S; Wang S
    Tohoku J Exp Med; 2014 Jan; 232(1):9-19. PubMed ID: 24429392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value of CD44 expression in non-small cell lung cancer: a systematic review.
    Luo Z; Wu RR; Lv L; Li P; Zhang LY; Hao QL; Li W
    Int J Clin Exp Pathol; 2014; 7(7):3632-46. PubMed ID: 25120740
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD44v6 overexpression related to metastasis and poor prognosis of colorectal cancer: A meta-analysis.
    Wang JL; Su WY; Lin YW; Xiong H; Chen YX; Xu J; Fang JY
    Oncotarget; 2017 Feb; 8(8):12866-12876. PubMed ID: 28030817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic and Clinical Value of CD44 and CD133 in Esophageal Cancer: A Systematic Review and Meta-analysis.
    Kamil Mohammed Al-Mosawi A; Cheshomi H; Hosseinzadeh A; M Matin M
    Iran J Allergy Asthma Immunol; 2020 Apr; 19(2):105-116. PubMed ID: 32372624
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD44 Predicts Early Recurrence in Pancreatic Cancer Patients Undergoing Radical Surgery.
    Hsu CP; Lee LY; Hsu JT; Hsu YP; Wu YT; Wang SY; Yeh CN; Chen TC; Hwang TL
    In Vivo; 2018; 32(6):1533-1540. PubMed ID: 30348713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of CD44 variants and its association with survival in pancreatic cancer.
    Gotoda T; Matsumura Y; Kondo H; Saitoh D; Shimada Y; Kosuge T; Kanai Y; Kakizoe T
    Jpn J Cancer Res; 1998 Oct; 89(10):1033-40. PubMed ID: 9849582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of UGP2 and CFL1 expression levels in benign and malignant pancreatic lesions and their clinicopathological significance.
    Wang L; Xiong L; Wu Z; Miao X; Liu Z; Li D; Zou Q; Yang Z
    World J Surg Oncol; 2018 Jan; 16(1):11. PubMed ID: 29347944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD44/CD24 expression in recurrent gastric cancer: a retrospective analysis.
    Yong CS; Ou Yang CM; Chou YH; Liao CS; Lee CW; Lee CC
    BMC Gastroenterol; 2012 Jul; 12():95. PubMed ID: 22839505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic role of HER2 amplification based on fluorescence in situ hybridization (FISH) in pancreatic ductal adenocarcinoma (PDAC): a meta-analysis.
    Li X; Zhao H; Gu J; Zheng L
    World J Surg Oncol; 2016 Feb; 14(1):38. PubMed ID: 26897036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic role of the cancer stem cell marker CD44 in ovarian cancer: a meta-analysis.
    Shi YY; Jiang H
    Genet Mol Res; 2016 Aug; 15(3):. PubMed ID: 27525945
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD44 SNPrs187115: A Novel Biomarker Signature that Predicts Survival in Resectable Pancreatic Ductal Adenocarcinoma.
    Stracquadanio G; Vrugt B; Flury R; Schraml P; Würl P; Müller TH; Knippschild U; Henne-Bruns D; Breitenstein S; Clavien PA; Graf R; Bond GL; Grochola LF
    Clin Cancer Res; 2016 Dec; 22(24):6069-6077. PubMed ID: 27283965
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinicopathological and prognostic significance of metastasis-associated in colon cancer-1 (MACC1) overexpression in colorectal cancer: a meta-analysis.
    Zhao Y; Dai C; Wang M; Kang H; Lin S; Yang P; Liu X; Liu K; Xu P; Zheng Y; Li S; Dai Z
    Oncotarget; 2016 Sep; 7(39):62966-62975. PubMed ID: 27542234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.